GOFEN & GLOSSBERG LLC /IL/ – Vertex Pharmaceuticals Incorporated Transaction History
GOFEN & GLOSSBERG LLC /IL/ portfolio value:
$839,000
portfolio value
GOFEN & GLOSSBERG LLC /IL/ quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.28% | 8 shares | 25K | $289.54 | 2.89K |
| Q2 2022 | share | Decrease | -6.66% | -206 shares | 7K | $281.79 | 2.88K |
| Q1 2022 | share | 0.00% | 0 shares | 128K | $260.97 | 3.09K | |
| Q4 2021 | share | Decrease | -0.99% | -31 shares | 112K | $222.45 | 3.09K |
| Q3 2021 | share | Increase | +1.00% | 31 shares | -57K | $181.39 | 3.12K |
| Q2 2021 | share | Decrease | -9.53% | -326 shares | -111K | $201.63 | 3.09K |
| Q1 2021 | share | Decrease | -1.01% | -35 shares | -82K | $214.89 | 3.42K |
| Q4 2020 | share | Decrease | -1.20% | -42 shares | -135K | $236.34 | 3.45K |
| Q3 2020 | share | Increase | +6.26% | 206 shares | -3K | $272.12 | 3.49K |
| Q2 2020 | share | 0.00% | 0 shares | 172K | $290.31 | 3.29K | |
| Q1 2020 | share | Increase | +0.40% | 13 shares | 65K | $237.95 | 3.29K |
| Q4 2019 | share | Decrease | -2.21% | -74 shares | 150K | $218.95 | 3.27K |
| Q3 2019 | share | Increase | +1.27% | 42 shares | -39K | $169.42 | 3.35K |
| Q2 2019 | share | 0.00% | 0 shares | -2K | $183.38 | 3.31K | |
| Q1 2019 | share | 0.00% | 0 shares | 60K | $183.95 | 3.31K | |
| Q4 2018 | share | 0.00% | 0 shares | -89K | $165.71 | 3.31K | |
| Q3 2018 | share | 0.00% | 0 shares | 75K | $192.74 | 3.31K | |
| Q2 2018 | share | 0.00% | 0 shares | 24K | $169.96 | 3.31K | |
| Q1 2018 | share | 0.00% | 0 shares | 43K | $162.98 | 3.31K | |
| Q4 2017 | share | 0.00% | 0 shares | -7K | $149.86 | 3.31K | |
| Q3 2017 | share | 0.00% | 0 shares | 76K | $152.04 | 3.31K | |
| Q2 2017 | share | Decrease | -1.49% | -50 shares | 60K | $128.87 | 3.31K |
| Q1 2017 | share | Decrease | -1.15% | -39 shares | 117K | $109.35 | 3.36K |
| Q4 2016 | share | 0.00% | 0 shares | -46K | $73.67 | 3.39K | |
| Q3 2016 | share | 0.00% | 0 shares | 4K | $87.21 | 3.39K | |
| Q2 2016 | share | Decrease | -5.61% | -202 shares | 6K | $86.02 | 3.39K |
| Q1 2016 | share | Increase | +2.59% | 91 shares | -156K | $79.49 | 3.60K |